ACOG logo
ACOG NASDAQ CA

Alpha Cognition Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2021
$5.98
▲ +$0.02 (+0.34%)
Vol 56K
2
Quality Score
fail
Mkt Cap
$141.3M
ROE
-52.6%
D/E
0.00
Beta
9.92
52W
$4–$12

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Earnings

Beat rate: 40.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.28 $-0.31 $-0.03
Sep 2025 $-0.44 $-0.08 +$0.36
Jun 2025 $-0.52 $-0.65 $-0.13
Mar 2025 $-0.59 $-0.13 +$0.46

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -52.6%
P/E (TTM)
Net Margin -632.7%
Gross Margin 67.8%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 14.69 17.14 14.69 14.69 14.69 6.69

Key Ratios

ROA (TTM)
-40.8%
EPS (TTM)
$-1.37
52W High
$11.54
52W Low
$3.75
$3.75 52-Week Range $11.54

How does ACOG compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ACOG AAPG ABEO ABOS ABP

ACOG valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ACOG profitability vs Biotechnology peers

ROE
-52.6%
22% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-40.8%
13% above peers (-46.7%)
vs Peers
vs Industry
In line

ACOG financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.7
51% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
9.9
923% above peers (1.0)
vs Peers
vs Industry
More volatile

ACOG fundamentals radar

ACOG Peer median Industry

ACOG profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ACOG vs peers: key metrics

Latest News

No related news yet